+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

North America Diabetes Care Devices Market to 2027 - Regional Analysis and Forecasts by Product; End User; and Country

  • ID: 4801438
  • Report
  • Region: North America, United States
  • 140 pages
  • The Insight Partners
UP TO OFF
until Jan 15th 2020
1 of 3

FEATURED COMPANIES

  • B. Braun Melsungen AG
  • BD
  • Dexcom, Inc.
  • Eli Lilly and Company
  • F. Hoffman-LA Roche Ltd.
  • Insulet Corporation
  • MORE
The North America diabetes care devices market is expected to reach US$ 15,300.0 Mn in 2027 from US$ 8,936.5 Mn in 2018. The market is estimated to grow with a CAGR of 6.3% from 2019-2027.

The growth of the diabetes care devices market is primarily attributed to the growing geriatric population and rapid technological advancements in diabetes care devices. However, high cost of diabetes care devices and risks associated with the insulin delivery devices are likely to pose a negative impact on the market growth. On the other hand, development of cost efficient pen needles is likely to have a positive impact on the growth of the North America diabetes care devices market in the coming years.

The advancement in the field of the healthcare industry is driving to the players for more research and developments for insulin delivery devices. There are many methods to deliver insulin into the body such as needles, insulin pens and insulin pumps. Insulin pumps are small computerized diabetes management devises, connected with cannula under the skin that is used to deliver a slow continuous level of insulin. The program can be controlled by the individual depends on the more or less requirement. The increasing advancements and technology in glucose monitoring devices have result into smaller required blood volumes with improved accuracy. The ability to transfer data between the blood glucose (BG) meter and insulin delivery devices has been also improved. The increasing advancements in blood glucose (BG) monitoring technology have resulted in improved accuracy, smaller required blood volumes, and the ability to transfer data between the BG meter and insulin delivery devices. For instance, in September 2016, the FDA announced their first automatically automatic glucose monitoring device, Medtronic’s MiniMed 670G which is a hybrid closed looped system that provide suitable insulin doses in patient of age 14 years and above with diabetes type 1. Pen needles and syringes are the most commonly used device for injecting insulin to the diabetic patients. In addition, to reduce the injection site repetition for drug administration, montméd Inc. in April 2017 introduced a new a variant of SiteSmart colored pen needles to keep the injection site tissue healthy and promote better insulin adoption. Thus, the technological advancements coupled with increasing influx of new products into the market is expected to propel the growth of global pen needles market over the forecast years.

In 2018, the glucose monitoring devices segment held a largest market share of 54.2% of the diabetes care devices market, by product. The glucose monitoring devices is expected to dominate its market share in 2027 owing to the rise in the prevalence of the diabetes and presence of the several market players that offers technically advanced products. The testing strips segment among the glucose monitoring devices is anticipated to witness the fastest growth rate of 7.2% during the forecast period, 2019 to 2027 owing to the enormous usages in the glucose monitoring devices.

Homecare held a largest market share of 59.9% of the diabetes care devices market, by end user in 2018. This segment is also expected to dominate the market in 2027 owing to the rise in the demand for the glucose monitoring devices and insulin delivery devices. Increasing diabetic population, the ease of use, availability, and accessibility of insulin delivery devices has also increased the adoption of self-administration among patients is anticipated to grow at a steady rate during the forecast period. Also the homecare segment is also expected to grow at the fastest growth rate of 6.6% during the forecast period, 2019 to 2027.

Some of the major primary and secondary sources for diabetes care devices included in the report are, Associação de Diabetes Juvenil (ADJ), Centers for Disease Control and Prevention (CDC), Food and Drug Administration (FDA), International Diabetes Federation(IDF) National Institute for Health and Care Excellence (NICE) and others.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • B. Braun Melsungen AG
  • BD
  • Dexcom, Inc.
  • Eli Lilly and Company
  • F. Hoffman-LA Roche Ltd.
  • Insulet Corporation
  • MORE

Part 1. Introduction
1.1 Scope of the Study
1.2 Report Guidance

Part 2. North America Diabetes Care Devices Market - Key Takeaways

Part 3. North America Diabetes Care Devices Market - Market Landscape
3.1 overview
3.2 market segmentation
3.2.1 North America Diabetes Care Devices Market - By Product
3.2.2 North America Diabetes Care Devices Market - By End User
3.2.3 North America Diabetes Care Devices Market - By Country
3.3 PEST Analysis

Part 4. North America Diabetes Care Devices Market - Key Market Dynamics
4.1 Key Market Drivers
4.1.1 Growing Geriatric Population
4.1.2 Rapid Technological Advancements in Diabetes Care Devices
4.2 Key Market Restraints
4.2.1 High Cost of Diabetes Care Devices
4.2.2 Risks Associated with the Insulin Delivery Devices
4.3 Key Market Opportunities
4.3.1 Development of Cost Efficient Pen Needles
4.4 future Trends
4.4.1 Growing Product Innovations
4.5 Impact analysis

Part 5. Diabetes Care Devices Market - North America Analysis
5.1 North America DIABETES CARE DEVICES market Revenue Forecasts and Analysis
5.2 Market positioning
5.3 PERFORMANCE OF KEY PLAYERS
5.3.1 Medtronic
5.3.2 F. Hoffmann-La Roche Ltd.

Part 6. North America Diabetes Care Devices Market Analysis - By Product
6.1 overview
6.2 North America diabetes care devices Market BY Product, 2018 & 2027 (%)
6.3 North America DIABETES CARE DEVICES market Revenue And Forecasts to 2027, By Product (US$ Mn)
6.3.1 North America Glucose Monitoring Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)
6.3.2 North America Insulin Delivery Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)
6.4 Glucose Monitoring Devices Market
6.4.1 Overview
6.4.2 North America Glucose Monitoring Devices Market Revenue and Forecast to 2027 (US$ Mn)
6.4.3 Glucometers Market
6.4.3.1 Overview
6.4.3.2 North America Glucometers Market Revenue and Forecast to 2027 (US$ Mn)
6.4.4 Lancets Market
6.4.4.1 Overview
6.4.4.2 North America Lancets Market Revenue and Forecast to 2027 (US$ Mn)
6.4.5 Testing Strips Market
6.4.5.1 Overview
6.4.5.2 North America Testing Strips Market Revenue and Forecast to 2027 (US$ Mn)
6.4.6 Other Glucose Monitoring Devices Market
6.4.6.1 Overview
6.4.6.2 North America Other Glucose Monitoring Devices Market Revenue and Forecast to 2027 (US$ Mn)
6.5 Insulin Delivery Devices Market
6.5.1 Overview
6.5.2 North America Insulin Delivery Devices Market Revenue and Forecast to 2027 (US$ Mn)
6.5.3 Insulin Pens Market
6.5.3.1 Overview
6.5.3.2 North America Insulin Pens Market Revenue and Forecast to 2027 (US$ Mn)
6.5.4 Insulin Syringes Market
6.5.4.1 Overview
6.5.4.2 North America Insulin Syringes Market Revenue and Forecast to 2027 (US$ Mn)
6.5.5 Insulin Pumps Market
6.5.5.1 Overview
6.5.5.2 North America Insulin Pumps Market Revenue and Forecast to 2027 (US$ Mn)
6.5.6 Other Insulin Delivery Devices Market
6.5.6.1 Overview
6.5.6.2 North America Insulin Delivery Devices Market Revenue and Forecast to 2027 (US$ Mn)

Part 7. North America Diabetes Care Devices Market Analysis - By End User
7.1 Overview
7.2 NORTH AMERICA DIABETES CARE DEVICES MARKET, BY End User, 2018 & 2027 (%)
7.3 North America DIABETES CARE DEVICES market Revenue And Forecasts to 2027, By End User (US$ Mn)
7.4 Homecare Market
7.4.1 Overview
7.4.2 North America Homecare Market Revenue and Forecasts to 2027 (US$ Mn)
7.5 hospitals & Clinics Market
7.5.1 Overview
7.5.2 North America Hospitals & Clinics Market Revenue and Forecasts to 2027 (US$ Mn)

Part 8. North America Diabetes Care Devices Market Revenue And Forecasts To 2027
8.1 Overview
8.2 North America DIABETES CARE DEVICES market Revenue and Forecasts to 2027 (US$ Mn)
8.3 North America DIABETES CARE DEVICES market Revenue And Forecasts to 2027, By Product (US$ Mn)
8.3.1 North America Glucose Monitoring Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.3.2 North America Insulin Delivery Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.4 North America DIABETES CARE DEVICES market Revenue And Forecasts to 2027, By End User (US$ Mn)
8.5 North America Diabetes care devices Market Revenue And Forecasts to 2027, By Country (%)
8.6 US DIABETES CARE DEVICES market Revenue and Forecasts to 2027 (US$ Mn)
8.6.1 US Diabetes Care Devices Market Revenue and Forecasts to 2027 (US$ Mn)
8.6.2 US Diabetes Care Devices Market Revenue And Forecasts to 2027, By Product (US$ Mn)
8.6.2.1 US Glucose Monitoring Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.6.2.2 US Insulin Delivery Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.6.3 US Diabetes Care Devices Market Revenue And Forecasts to 2027, By End User (US$ Mn)
8.7 Canada Diabetes care devices Market Revenue and Forecasts to 2027 (US$ Mn)
8.7.1 Canada Diabetes Care Devices Market Revenue and Forecasts to 2027 (US$ Mn)
8.7.2 Canada Diabetes Care Devices Market Revenue And Forecasts to 2027, By Product (US$ Mn)
8.7.2.1 Canada Glucose Monitoring Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.7.2.2 Canada Insulin Delivery Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.7.3 Canada Diabetes Care Devices Market Revenue And Forecasts to 2027, By End User (US$ Mn)
8.8 Mexico Diabetes care devices Market Revenue and Forecasts to 2027 (US$ Mn)
8.8.1 Mexico Diabetes Care Devices Market Revenue and Forecasts to 2027 (US$ Mn)
8.8.2 Mexico Diabetes Care Devices Market Revenue And Forecasts to 2027, By Product (US$ Mn)
8.8.2.1 Mexico Glucose Monitoring Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.8.2.2 Mexico Insulin Delivery Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.8.3 Mexico Diabetes Care Devices Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Part 9. Diabetes Care Devices Market - Industry Landscape
9.1 Overview
9.2 Comparative Company Analysis
9.3 Growth Strategies done by the companies in the Market, (%)
9.4 Organic Developments
9.4.1 Overview
9.5 Inorganic developments
9.5.1 Overview

Part 10. Diabetes Care Devices Market-Key Company Profiles
10.1 BD
10.1.1 Key Facts
10.1.2 Business Description
10.1.3 Financial Overview
10.1.4 Product Portfolio
10.1.5 SWOT Analysis
10.1.6 Key Developments
10.2 novo nordisk a/s
10.2.1 Key Facts
10.2.2 Business Description
10.2.3 Financial Overview
10.2.4 Product Portfolio
10.2.5 SWOT Analysis
10.2.6 Key Developments
10.3 B. Braun Melsungen AG
10.3.1 Key Facts
10.3.2 Business Description
10.3.3 Financial Overview
10.3.4 Product Portfolio
10.3.5 SWOT Analysis
10.3.6 Key Developments
10.4 Medtronic
10.4.1 Key Facts
10.4.2 Business Description
10.4.3 Financial Information
10.4.4 Product Portfolio
10.4.5 SWOT Analysis
10.4.6 Key Developments
10.5 Tandem Diabetes Care, Inc.
10.5.1 Key Facts
10.5.2 Business Description
10.5.3 Financial Information
10.5.4 Product Portfolio
10.5.5 SWOT Analysis
10.5.6 Key Developments
10.6 Insulet Corporation
10.6.1 Key Facts
10.6.2 Business Description
10.6.3 Financial Information
10.6.4 Product Portfolio
10.6.5 SWOT Analysis
10.6.6 Key Developments
10.7 Eli lilly and company
10.7.1 Key Facts
10.7.2 Business Description
10.7.3 Financial Overview
10.7.4 Product Portfolio
10.7.5 SWOT Analysis
10.7.6 Key Developments
10.8 Dexcom, Inc.
10.8.1 Key Facts
10.8.2 Business Description
10.8.3 Financial Overview
10.8.4 Product Portfolio
10.8.5 SWOT Analysis
10.8.6 Key Developments
10.9 Terumo Corporation
10.9.1 Key Facts
10.9.2 Business Description
10.9.3 Financial Overview
10.9.4 Product portfolio
10.9.5 SWOT ANALYSIS
10.9.6 KEY DEVELOPMENTS
10.10 F. Hoffmann-La Roche Ltd.
10.10.1 Key Facts
10.10.2 Business Description
10.10.3 Financial Overview
10.10.4 Product Portfolio
10.10.5 SWOT Analysis
10.10.6 Key Developments

Part 11. Appendix
11.1 About the Publisher
11.2 Glossary of Terms
11.3 Methodology
11.3.1 Coverage
11.3.2 Secondary Research
11.3.3 Primary Research

Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • BD
  • Novo Nordisk A/S
  • B. Braun Melsungen AG
  • Insulet Corporation
  • Medtronic
  • Tandem Diabetes Care, Inc.
  • Eli Lilly and Company
  • Dexcom, Inc.
  • Terumo Corporation
  • F. Hoffman-LA Roche Ltd.
Note: Product cover images may vary from those shown
Adroll
adroll